
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Antibody Structure and Function: The Basis for Engineering Therapeutics
Mark L. Chiu, Dennis R. Goulet, A. Teplyakov, et al.
Antibodies (2019) Vol. 8, Iss. 4, pp. 55-55
Open Access | Times Cited: 479
Mark L. Chiu, Dennis R. Goulet, A. Teplyakov, et al.
Antibodies (2019) Vol. 8, Iss. 4, pp. 55-55
Open Access | Times Cited: 479
Showing 1-25 of 479 citing articles:
Observed Antibody Space: A diverse database of cleaned, annotated, and translated unpaired and paired antibody sequences
Tobias Hegelund Olsen, Fergus Boyles, Charlotte M. Deane
Protein Science (2021) Vol. 31, Iss. 1, pp. 141-146
Open Access | Times Cited: 195
Tobias Hegelund Olsen, Fergus Boyles, Charlotte M. Deane
Protein Science (2021) Vol. 31, Iss. 1, pp. 141-146
Open Access | Times Cited: 195
Fc-Engineering for Modulated Effector Functions—Improving Antibodies for Cancer Treatment
Rena Liu, Robert J. Oldham, Emma Teal, et al.
Antibodies (2020) Vol. 9, Iss. 4, pp. 64-64
Open Access | Times Cited: 166
Rena Liu, Robert J. Oldham, Emma Teal, et al.
Antibodies (2020) Vol. 9, Iss. 4, pp. 64-64
Open Access | Times Cited: 166
Antibody–Drug Conjugates—A Tutorial Review
Stephanie Baah, Mark Laws, Khondaker Miraz Rahman
Molecules (2021) Vol. 26, Iss. 10, pp. 2943-2943
Open Access | Times Cited: 166
Stephanie Baah, Mark Laws, Khondaker Miraz Rahman
Molecules (2021) Vol. 26, Iss. 10, pp. 2943-2943
Open Access | Times Cited: 166
ImmuneBuilder: Deep-Learning models for predicting the structures of immune proteins
Brennan Abanades, Wing Ki Wong, Fergus Boyles, et al.
Communications Biology (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 160
Brennan Abanades, Wing Ki Wong, Fergus Boyles, et al.
Communications Biology (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 160
Avidity in antibody effector functions and biotherapeutic drug design
Simone C. Oostindie, Greg A. Lazar, Janine Schuurman, et al.
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 10, pp. 715-735
Open Access | Times Cited: 142
Simone C. Oostindie, Greg A. Lazar, Janine Schuurman, et al.
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 10, pp. 715-735
Open Access | Times Cited: 142
ABlooper: fast accurate antibody CDR loop structure prediction with accuracy estimation
Brennan Abanades, Guy Georges, Alexander Bujotzek, et al.
Bioinformatics (2022) Vol. 38, Iss. 7, pp. 1877-1880
Open Access | Times Cited: 109
Brennan Abanades, Guy Georges, Alexander Bujotzek, et al.
Bioinformatics (2022) Vol. 38, Iss. 7, pp. 1877-1880
Open Access | Times Cited: 109
Functional ligands for improving anticancer drug therapy: current status and applications to drug delivery systems
Rajiv Bajracharya, Jae Geun Song, Basavaraj R. Patil, et al.
Drug Delivery (2022) Vol. 29, Iss. 1, pp. 1959-1970
Open Access | Times Cited: 104
Rajiv Bajracharya, Jae Geun Song, Basavaraj R. Patil, et al.
Drug Delivery (2022) Vol. 29, Iss. 1, pp. 1959-1970
Open Access | Times Cited: 104
AFsample: improving multimer prediction with AlphaFold using massive sampling
Björn Wallner
Bioinformatics (2023) Vol. 39, Iss. 9
Open Access | Times Cited: 101
Björn Wallner
Bioinformatics (2023) Vol. 39, Iss. 9
Open Access | Times Cited: 101
Aptasensors versus immunosensors—Which will prevail?
Sofia Arshavsky‐Graham, Christopher Heuer, Jiang Xin, et al.
Engineering in Life Sciences (2022) Vol. 22, Iss. 3-4, pp. 319-333
Open Access | Times Cited: 84
Sofia Arshavsky‐Graham, Christopher Heuer, Jiang Xin, et al.
Engineering in Life Sciences (2022) Vol. 22, Iss. 3-4, pp. 319-333
Open Access | Times Cited: 84
Advances in computational structure-based antibody design
Alissa Hummer, Brennan Abanades, Charlotte M. Deane
Current Opinion in Structural Biology (2022) Vol. 74, pp. 102379-102379
Open Access | Times Cited: 69
Alissa Hummer, Brennan Abanades, Charlotte M. Deane
Current Opinion in Structural Biology (2022) Vol. 74, pp. 102379-102379
Open Access | Times Cited: 69
Cutting-edge approaches for targeted drug delivery in breast cancer: beyond conventional therapies
Ramesh Chaudhari, Vishva Patel, Ashutosh Kumar
Nanoscale Advances (2024) Vol. 6, Iss. 9, pp. 2270-2286
Open Access | Times Cited: 16
Ramesh Chaudhari, Vishva Patel, Ashutosh Kumar
Nanoscale Advances (2024) Vol. 6, Iss. 9, pp. 2270-2286
Open Access | Times Cited: 16
Targeting PAI-1 in Cardiovascular Disease: Structural Insights Into PAI-1 Functionality and Inhibition
Machteld Sillen, Paul Declerck
Frontiers in Cardiovascular Medicine (2020) Vol. 7
Open Access | Times Cited: 107
Machteld Sillen, Paul Declerck
Frontiers in Cardiovascular Medicine (2020) Vol. 7
Open Access | Times Cited: 107
Mesoporous Silica Nanoparticles: Properties and Strategies for Enhancing Clinical Effect
Alex N. Frickenstein, Jordan M. Hagood, Collin Britten, et al.
Pharmaceutics (2021) Vol. 13, Iss. 4, pp. 570-570
Open Access | Times Cited: 80
Alex N. Frickenstein, Jordan M. Hagood, Collin Britten, et al.
Pharmaceutics (2021) Vol. 13, Iss. 4, pp. 570-570
Open Access | Times Cited: 80
Ongoing Challenges to Develop High Concentration Monoclonal Antibody-based Formulations for Subcutaneous Administration: Quo Vadis?
Wim Jiskoot, Andrea Hawe, Tim Menzen, et al.
Journal of Pharmaceutical Sciences (2021) Vol. 111, Iss. 4, pp. 861-867
Open Access | Times Cited: 64
Wim Jiskoot, Andrea Hawe, Tim Menzen, et al.
Journal of Pharmaceutical Sciences (2021) Vol. 111, Iss. 4, pp. 861-867
Open Access | Times Cited: 64
Antibody‐Incorporated Nanomedicines for Cancer Therapy
Shun‐Yu Wu, Fu‐Gen Wu, Xiaoyuan Chen
Advanced Materials (2022) Vol. 34, Iss. 24
Closed Access | Times Cited: 64
Shun‐Yu Wu, Fu‐Gen Wu, Xiaoyuan Chen
Advanced Materials (2022) Vol. 34, Iss. 24
Closed Access | Times Cited: 64
Single-Chain Fragment Variable: Recent Progress in Cancer Diagnosis and Therapy
Paola Muñoz-López, Rosa María Ribas‐Aparicio, Elayne Irene Becerra-Báez, et al.
Cancers (2022) Vol. 14, Iss. 17, pp. 4206-4206
Open Access | Times Cited: 50
Paola Muñoz-López, Rosa María Ribas‐Aparicio, Elayne Irene Becerra-Báez, et al.
Cancers (2022) Vol. 14, Iss. 17, pp. 4206-4206
Open Access | Times Cited: 50
Improving Antibody Therapeutics by Manipulating the Fc Domain: Immunological and Structural Considerations
George Delidakis, Jin Eyun Kim, Katia George, et al.
Annual Review of Biomedical Engineering (2022) Vol. 24, Iss. 1, pp. 249-274
Open Access | Times Cited: 49
George Delidakis, Jin Eyun Kim, Katia George, et al.
Annual Review of Biomedical Engineering (2022) Vol. 24, Iss. 1, pp. 249-274
Open Access | Times Cited: 49
Challenges in antibody structure prediction
Monica L. Fernández‐Quintero, Janik Kokot, Franz Waibl, et al.
mAbs (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 30
Monica L. Fernández‐Quintero, Janik Kokot, Franz Waibl, et al.
mAbs (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 30
Blueprint for antibody biologics developability
Carl Mieczkowski, Xuejin Zhang, Dana Lee, et al.
mAbs (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 30
Carl Mieczkowski, Xuejin Zhang, Dana Lee, et al.
mAbs (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 30
Production of monoclonal antibodies for therapeutic purposes: A review
Waller-Pulido Alejandra, Miriam Jimenez-Perez, Gonzalez-Sanchez Fabio Antonio, et al.
International Immunopharmacology (2023) Vol. 120, pp. 110376-110376
Closed Access | Times Cited: 29
Waller-Pulido Alejandra, Miriam Jimenez-Perez, Gonzalez-Sanchez Fabio Antonio, et al.
International Immunopharmacology (2023) Vol. 120, pp. 110376-110376
Closed Access | Times Cited: 29
Recent Advances in the Development of Monoclonal Antibodies and Next-Generation Antibodies
Rohit Singh, Pankaj Chandley, Soma Rohatgi
ImmunoHorizons (2023) Vol. 7, Iss. 12, pp. 886-897
Open Access | Times Cited: 29
Rohit Singh, Pankaj Chandley, Soma Rohatgi
ImmunoHorizons (2023) Vol. 7, Iss. 12, pp. 886-897
Open Access | Times Cited: 29
Artificial intelligence in cancer immunotherapy: Applications in neoantigen recognition, antibody design and immunotherapy response prediction
Li Tong, Yupeng Li, Xiaoyi Zhu, et al.
Seminars in Cancer Biology (2023) Vol. 91, pp. 50-69
Closed Access | Times Cited: 25
Li Tong, Yupeng Li, Xiaoyi Zhu, et al.
Seminars in Cancer Biology (2023) Vol. 91, pp. 50-69
Closed Access | Times Cited: 25
Application Progress of the Single Domain Antibody in Medicine
Huaping Tang, Yuan Gao, Jiangyuan Han
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 4176-4176
Open Access | Times Cited: 22
Huaping Tang, Yuan Gao, Jiangyuan Han
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 4176-4176
Open Access | Times Cited: 22
Emerging Applications of Nanobiosensors in Pathogen Detection in Water and Food
Hiram Martín Valenzuela-Amaro, Alberto Aguayo-Acosta, Edgar Ricardo Meléndez-Sánchez, et al.
Biosensors (2023) Vol. 13, Iss. 10, pp. 922-922
Open Access | Times Cited: 22
Hiram Martín Valenzuela-Amaro, Alberto Aguayo-Acosta, Edgar Ricardo Meléndez-Sánchez, et al.
Biosensors (2023) Vol. 13, Iss. 10, pp. 922-922
Open Access | Times Cited: 22
The Role of Force Fields and Water Models in Protein Folding and Unfolding Dynamics
Anna-Lena M. Fischer, Anna Tichy, Janik Kokot, et al.
Journal of Chemical Theory and Computation (2024) Vol. 20, Iss. 5, pp. 2321-2333
Open Access | Times Cited: 13
Anna-Lena M. Fischer, Anna Tichy, Janik Kokot, et al.
Journal of Chemical Theory and Computation (2024) Vol. 20, Iss. 5, pp. 2321-2333
Open Access | Times Cited: 13